# Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)

> **NCT00590044** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 74 (actual)

## Conditions studied

- Diabetic Ketoacidosis

## Interventions

- **DRUG:** insulin glargine+ glulisine
- **DRUG:** NPH + Regular insulin

## Key facts

- **NCT ID:** NCT00590044
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-06
- **Final completion:** 2008-08
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2018-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00590044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00590044, "Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00590044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*